{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:12Z","timestamp":1793321052443,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#MCDC2204-011"],"award-info":[{"award-number":["#MCDC2204-011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ebiom.2025.105698","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:53:49Z","timestamp":1744476829000},"page":"105698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-8176","authenticated-orcid":false,"given":"David W.","family":"Hawman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Meade-White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Prado-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Saturday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-8596","authenticated-orcid":false,"given":"Henry","family":"Buda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-865X","authenticated-orcid":false,"given":"Lenny","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1612-2697","authenticated-orcid":false,"given":"Jesse","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8227","authenticated-orcid":false,"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2025.105698_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Ergonul","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105698_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41579-023-00871-9","article-title":"Crimean-Congo haemorrhagic fever virus","volume":"21","author":"Hawman","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105698_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104188","article-title":"Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"82","author":"Leventhal","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105698_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105017","article-title":"Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice","volume":"101","author":"Leventhal","year":"2024","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105698_bib5","article-title":"Ribavirin for treating Crimean Congo haemorrhagic fever","volume":"6","author":"Johnson","year":"2018","journal-title":"Cochr Database Syst Rev"},{"issue":"44","key":"10.1016\/j.ebiom.2025.105698_bib6","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1016\/j.vaccine.2012.08.003","article-title":"Healthy individuals\u2019 immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine","volume":"30","author":"Mousavi-Jazi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105698_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41541-024-00887-z","article-title":"A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever","volume":"9","author":"Hawman","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105698_bib8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/v6062392","article-title":"Alphavirus-based vaccines","volume":"6","author":"Lundstrom","year":"2014","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105698_bib9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/vaccines11010130","article-title":"An RNA-based vaccine platform for use against Mycobacterium tuberculosis","volume":"11","author":"Larsen","year":"2023","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105698_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011298","article-title":"A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned","volume":"19","author":"O\u2019Connor","year":"2023","journal-title":"PLoS Pathog"},{"issue":"555","key":"10.1016\/j.ebiom.2025.105698_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.105698_bib13","series-title":"HDT bio\u2019s COVID-19 vaccine wins regulatory approval in India","year":"2022"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105698_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41564-018-0141-7","article-title":"A cynomolgus macaque model for Crimean-Congo haemorrhagic fever","volume":"3","author":"Haddock","year":"2018","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105698_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2025.105698_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104858","article-title":"Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques","volume":"181","author":"Hawman","year":"2020","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105698_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ymthe.2022.09.016","article-title":"Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model","volume":"31","author":"Hawman","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2025.105698_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2018.06.013","article-title":"Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice","volume":"157","author":"Hawman","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.ebiom.2025.105698_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63906","article-title":"Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus","volume":"10","author":"Hawman","year":"2021","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105698_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02289823","article-title":"On methods in the analysis of profile data","volume":"24","author":"Greenhouse","year":"1959","journal-title":"Psychometrika"},{"issue":"260","key":"10.1016\/j.ebiom.2025.105698_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105698_bib22","doi-asserted-by":"crossref","first-page":"e0008637","DOI":"10.1371\/journal.pntd.0008637","article-title":"Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys","volume":"14","author":"Cross","year":"2020","journal-title":"PLoS Neglected Trop Dis"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105698_bib23","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1073\/pnas.0800159105","article-title":"TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved","volume":"105","author":"Keeble","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib24","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1038\/s41467-024-53362-7","article-title":"Antibodies targeting the crimean-Congo hemorrhagic fever virus nucleoprotein protect via TRIM21","volume":"15","author":"Leventhal","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105698_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01568-21","article-title":"Nucleoside-modified mRNA vaccines protect IFNAR(-\/-) mice against Crimean Congo hemorrhagic fever virus infection","volume":"96","author":"Appelberg","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.105698_bib26","article-title":"Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates","author":"Erasmus","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-024-46110-4","article-title":"Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus","volume":"15","author":"Garrison","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105698_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199173","article-title":"Induced protection from a CCHFV-M DNA vaccine requires CD8(+) T cells","volume":"334","author":"Golden","year":"2023","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-021-00293-9","article-title":"A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice","volume":"6","author":"Suschak","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-023-00663-5","article-title":"GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus","volume":"8","author":"Scher","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105698_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but No protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vect Borne Zoonotic Dis (Larchmont, NY)"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105698_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/biores.2019.0057","article-title":"Crimean-Congo hemorrhagic fever virus: advances in vaccine development","volume":"9","author":"Tipih","year":"2020","journal-title":"Biores Open Access"},{"key":"10.1016\/j.ebiom.2025.105698_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104839","article-title":"CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice","volume":"97","author":"Rao","year":"2023","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105698_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"Dowall","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105698_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091516","article-title":"A novel vaccine against crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"Buttigieg","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105698_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006149","article-title":"Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection","volume":"11","author":"Goedhals","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105698_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104523","article-title":"Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model","volume":"90","author":"Saunders","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105698_bib39","series-title":"First volunteers receive vaccine for Crimean-Congo haemorrhagic fever in Oxford clinical trial","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105698_bib40","series-title":"Phase I vaccine study of MVA-CCHF","author":"Authority","year":"2020"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105698_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008050","article-title":"Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis","volume":"15","author":"Smith","year":"2019","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105698_bib42","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105698_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.ebiom.2025.105698_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41541-024-01045-1","article-title":"Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice","volume":"9","author":"Leventhal","year":"2024","journal-title":"NPJ Vaccines"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:00Z","timestamp":1762618560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S2352396425001422"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105698","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105698"}}